Please provide your email address to receive an email when new articles are posted on . PET with a novel radiotracer met its primary endpoint for sensitivity and specificity of CAD detection, ...
Bone SPECT is better than FDG PET for detecting breast cancer that has spread (metastasized) to a patient's bones, according to researchers from Shizuoka Cancer Center Hospital in Japan. FDG PET is an ...
No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2006 ASCO Annual Meeting. This abstract does not include a full text component.
Whole cell preparations of MCF-7 breast carcinoma cells are more active than lysed cell preparations in lymphocyte blastogenesis assays (LBAs) of breast cancer patients No significant financial ...
A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more personalized treatment.
Cornell University and The General Hospital Corp. (Massachusetts General Hospital) have synthesized conjugates comprising a targeting moiety covalently linked to a radiolabeled metal chelator through ...
Researchers at Stichting AMC Foundation and Vrije Universiteit van Amsterdam have identified [18F]-labeled pyrazolidine-3,5-dione compounds targeting P2Y purinoceptor 12 (P2RY12; P2Y12) acting as PET ...
U-SPECT 7 CT from MILabs (a Rigaku company) offers unmatched preclinical dynamic and whole body Single Photon Emission Computed Tomography (SPECT) performance, integrated with diagnostic micro-CT.
GlobalData on MSN
FDA clears Spectrum Dynamics’ Veritas.AI platform
Veritas.AI is designed to advance the functionality of Spectrum Dynamics’ VERITON-CT scanner for nuclear imaging.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results